BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
PMBJP Records INR 935.25 Cr Worth Sales till Nov 2023 December 21, 2023 The impact of PMBJP is evident in the savings it offers to the public. In November 2023, consumers saved approximately INR 611.85 Cr by purchasing medicines from PMBJP Kendras instead of other retailers.
AstraZeneca Pharma India Launches COE For Severe Asthma Treatment In Mumbai December 20, 2023 The newly inaugurated CoE is equipped with advanced technologies for asthma management including biologics checklists and data-driven treatment approaches. Further, the center is expected to screen approximately 7,500+ patients within the first 12 months.
JB Chemicals Inks INR 1,089 Cr Deal, Acquires around 15 Ophthalmology Drugs December 20, 2023 Over the next three years, during the duration of the in-licensing agreement, Novartis will continue the manufacturing of the drugs, while JB Chemicals will focus on marketing and selling the products.
AstraZeneca's COPD Treatment Gains Approval from CDSCO December 20, 2023 COPD, the second leading cause of death in India, constitutes over 50% of chronic respiratory diseases and is the third leading cause of death globally.
PCI Starts Aadhaar Authentication Integration for Enhanced Regulatory Processes December 18, 2023 Last month, the Ministry of Health and Family Welfare (MoHFW) notified that PCI is authorised to perform Aadhaar authentication voluntarily for specific purposes related to digitising certain procedures.
Panacea Biotec Unveils World’s First Fully Liquid wP-IPV Pentavalent Vaccine December 18, 2023 EasyFourPol® stands as the first-ever fully liquid wP-IPV Pentavalent vaccine, safeguarding children against five deadly diseases including Diphtheria, Tetanus, Pertussis, Polio, and invasive infections from Haemophilus Influenza Type b.
K’taka Govt Extends Seed Funding to Biotech, Medtech & Health Startups December 18, 2023 Karnataka's startup ecosystem includes 14,000 startups, approximately 40 unicorns, and enjoys 8th rank in the Global Startup Ecosystem Index.
Granules India Secures USFDA Approval for Generic Pantoprazole Sodium Tablets December 14, 2023 These tablets are utilised for the short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD).
Biotech Will Become the Biggest Foundation for Health Treatment: Mandaviya December 12, 2023 Mandaviya noted that the Indian biotech industry is aiming to grow to $150 billion by 2025 and $300 billion by 2030, and India is currently among the top 12 destinations for Biotechnology in the world with approximately 3% share in the Global Biotechnology Industry.
DBT & BIRAC Launch 14 Novel Biotech Products December 11, 2023 This strategic move is part of a broader effort to boost the flagship initiatives of ‘Make in India’ and ‘Startup India’ for the biotech sector. It is expected to attract participation from over 30 countries, 500 exhibitors, 5000 delegates, and 1000 startups.
Zydus’ Methylene Blue Injection Gains USFDA Nod December 8, 2023 The approval was granted to Methylene Blue Injection in 10mg/2ml and 50mg/5ml formulations, allowing it to market in the US. The novel injection is an oxidation-reduction agent indicated for treating pediatric and adult patients with acquired methemoglobinemia.
Mylab's Multidrug-Resistant TB Test Now Integral to National TB Elimination Programme December 6, 2023 Recognised as India's first multidrug-resistant TB test, it is now an integral part of the Ni-kshay portal, enhancing the nation's capabilities in the battle against tuberculosis.
